ConceptioArchiveNCBI PubMed Central
NCBI PubMed Centralopen access

Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.

Seijas-Amigo J et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
behavioraleconomics
behavioral economics
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 193620
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.